2022 National Infusion Therapy Report Card

As the only national home infusion company accredited by The Joint Commission, we are focused on providing exceptional patient and clinical experiences, every time.

• We deliver better outcomes through clinical expertise and experience
• Our patients often experience better outcomes and fewer side effects, complications and readmissions
• With only a 4.1% unplanned readmission rate¹ and a 93.6% patient satisfaction rate², our proven results are made possible by our commitment to quality and safety in every single thing that we do

As an infusion provider that’s at the forefront of increasing access to high-quality care in the home, we are proud to share our latest national infusion therapy report card with you.

Review our 2022 Infusion Therapy Report Card.

Refer your patients to Coram^®*.

_{1. Coram National Home Infusion Results, January–December 2022. Clinical outcomes are self-reported and documented from the Coram Patient Record System HC360 and Epic. Comparable industry benchmarks are not available.}

_{2. Coram National Home Infusion Results, average patient satisfaction rate, independently monitored by Press Ganey, Inc., January-December 2022.}

_{*Coram CVS Specialty® Infusion Services}

_{Patient privacy is important to us. Our employees are trained regarding the appropriate way to handle patients’ private health information.}

_{©2023 CVS Health and/or one of its affiliates. All rights reserved.}